
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1023 | 982 | 997 | 614 | 836 | - |
Fund Return | 2.33% | -1.83% | -0.26% | -15.01% | -3.52% | - |
Place in category | 168 | 123 | 71 | 139 | 39 | - |
% in Category | 58 | 43 | 28 | 83 | 59 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDIII | 14.6B | -1.37 | 16.09 | 17.51 | ||
GF Stable Growth Mixed Assets Fund | 11.62B | -0.66 | -2.80 | 7.76 | ||
GF Tech Pioneer Alloc | 9.44B | -0.51 | -16.17 | - | ||
GF Global Selction Eq QDII | 8.68B | -1.21 | 15.96 | 12.86 | ||
GF Small-Cap Growth Stock Fd(LOF) | 5.84B | -0.59 | -16.44 | 5.47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS QY Medical Eq | 10.6B | 2.24 | -9.93 | - | ||
CMF CNI Bio Health Index | 9.81B | -0.05 | -20.13 | - | ||
Hwabao WP CSI Medical Index | 6.3B | 4.54 | -15.09 | - | ||
China Universal Healthcare Serv mix | 3.92B | 6.98 | -10.89 | - | ||
ICBCCS MedicalHlth Care Sect Secs I | 2.64B | 5.84 | -8.83 | 6.91 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 8.22 | 210.99 | -1.83% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 4.74 | 57.43 | +1.47% | |
Kelun Pharm A | CNE100000PW7 | 4.58 | 31.29 | -0.92% | |
Jiangsu Hengrui | CNE0000014W7 | 4.08 | 44.35 | -1.11% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 3.51 | 88.00 | -4.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review